1. Impact of pre‐existing interstitial lung abnormal shadow on lung injury development and severity in patients of non‐small cell lung cancer treated with osimertinib. (17th April 2022) Authors: Shibaki, Ryota; Ozawa, Yuichi; Noguchi, Susumu; Murakami, Yusuke; Takase, Eri; Azuma, Yuichiro; Maebeya, Masaru; Sugimoto, Takeya; Hayata, Atsushi; Hayakawa, Takahiro; Tamaki, Shinya; Nakanishi, Masanori; Teraoka, Shunsuke; Akamatsu, Hiroaki Journal: Cancer medicine Issue: Volume 11:Number 20(2022) Page Start: 3743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗